Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2021-12-13 Proxy Solicitation & In…
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南微医学科技股份有限公司关于召开2021年第三次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2021 third extraordinary general meeting of shareholders for 南微医学科技股份有限公司. It includes information about the meeting date, voting methods, agenda items, registration procedures, and proxy forms. There is no financial data or results reported, nor is it a transcript or presentation. It is clearly a formal announcement to shareholders about the meeting and voting process, which fits the definition of a Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters and it is not announcing the publication of a report but providing meeting materials and voting instructions.
2021-12-13 Chinese
南微医学科技股份有限公司关于2022年度日常关联交易额度预计事项的事前认可意见
Regulatory Filings
2021-12-13 Chinese
南微医学科技股份有限公司独立董事关于第三届董事会第六次会议相关事项的独立意见
Regulatory Filings
2021-12-13 Chinese
南微医学科技股份有限公司2020年限制性股票激励计划首次授予部分第一个归属期符合归属条件的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the first vesting period of a restricted stock incentive plan for the year 2020 by 南微医学科技股份有限公司. It includes specifics about the stock grant, vesting conditions, performance targets, approval procedures, and legal opinions. The content focuses on the stock incentive plan implementation and the confirmation that the vesting conditions have been met for a portion of the granted restricted shares. It is not a full financial report, earnings release, or management discussion, nor is it a proxy statement or voting result announcement. It is a regulatory announcement about the stock incentive plan's vesting status and related approvals. This type of document fits best under Regulatory Filings (RNS) as it is a formal disclosure of corporate actions related to stock incentives but does not constitute a full report or financial statement.
2021-12-13 Chinese
南微医学科技股份有限公司第三届监事会第五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 南微医学科技股份有限公司 regarding several internal company matters such as approval of stock incentive plan vesting, approval of hedging business, asset transfer related to affiliated transactions, and expected daily affiliated transaction limits for the next year. It includes voting results and references to other announcements published on the Shanghai Stock Exchange website. The document is short (1750 characters) and primarily reports on board meeting decisions rather than detailed financial data or full reports. It does not contain financial statements or detailed financial analysis. It is not an annual or interim report, earnings release, or audit report. It is not a regulatory filing or certification letter. It is a formal announcement of board resolutions and meeting outcomes, which fits best under Regulatory Filings (RNS) as a general announcement category for such disclosures that do not fit other specific categories.
2021-12-13 Chinese
南京证券股份有限公司关于南微医学科技股份有限公司全资子公司签订关联交易合同事项的核查意见
Regulatory Filings
2021-12-13 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.